1. Home
  2. Labeler Index
  3. Aphena Pharma Solutions - Tennessee, Llc
  4. 71610-808
  5. Product Images: Pregabalin

Product Images Pregabalin

View Photos of Packaging, Labels & Appearance

Table of Contents

  1. 71610-808-30 - 71610 808 30
  2. Aphena - Aphena
  3. Chemical Structure - pregabalin 01
  4. Figure 1 - pregabalin 02
  5. Figure 2 - pregabalin 03
  6. Figure 3 - pregabalin 04
  7. Figure 4 - pregabalin 05
  8. Figure 5 - pregabalin 06
  9. Figure 6 - pregabalin 07
  10. Figure 7 - pregabalin 08
  11. Figure 9 - pregabalin 09
  12. Figure 10 - pregabalin 10
  13. Figure 11 - pregabalin 11
  14. Figure 12 - pregabalin 12

Product Label Images

The following 14 images provide visual information about the product associated with Pregabalin NDC 71610-808 by Aphena Pharma Solutions - Tennessee, Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

71610-808-30 - 71610 808 30

71610-808-30 - 71610 808 30

This text appears to be a description of a medication named Pregabalin in the form of 30 capsules. The medication comes in 50 capsules per package with an NDC number 71610-808-30. The address of the manufacturer is mentioned as "260G v A P, Cokavie, TN 8508." The text also includes some other details related to the product labeling and possibly warnings or instructions.*

Aphena - Aphena

Aphena - Aphena

Chemical Structure - pregabalin 01

Chemical Structure - pregabalin 01

Figure 1 - pregabalin 02

Figure 1 - pregabalin 02

Figure 2 - pregabalin 03

Figure 2 - pregabalin 03

Figure 3 - pregabalin 04

Figure 3 - pregabalin 04

This is a data chart showing the percentage of patients who improved in pain with different dosages of Pregabalin and a placebo. The chart includes Pregabalin dosages of 300 mg, 150 mg, and 75 mg, each taken two times a day, as well as a placebo group. The percentages of improvement in pain from baseline are provided in the chart.*

Figure 4 - pregabalin 05

Figure 4 - pregabalin 05

Figure 5 - pregabalin 06

Figure 5 - pregabalin 06

Figure 6 - pregabalin 07

Figure 6 - pregabalin 07

Figure 7 - pregabalin 08

Figure 7 - pregabalin 08

Figure 9 - pregabalin 09

Figure 9 - pregabalin 09

This data displays the percent of patients improved with different doses of Pregabalin and Placebo in terms of pain relief. The percentages are shown for doses of 600mg, 450mg, and 300mg of Pregabalin per day, along with Placebo. Each value indicates the improvement in pain from baseline for the respective doses.*

Figure 10 - pregabalin 10

Figure 10 - pregabalin 10

Figure 11 - pregabalin 11

Figure 11 - pregabalin 11

Figure 12 - pregabalin 12

Figure 12 - pregabalin 12

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.